Fluticasone Propionate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

68 API Suppliers, 29 USDMF, 30 CEP/COS, 6 JDMF, 7 EU WC, 2 KDMF, 27 NDC API, 43 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

47 Drugs in Development

47 Drugs in Development

INTERMEDIATES

2 Intermediates Suppliers

2 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

429 FDF Dossiers, 70 FDA Orange Book, 212 Europe, 32 Canada, 13 Australia, 51 South Africa, 51 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT;TOPICAL - 0.005% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SPRAY, METERED;NASAL - 0.05MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SPRAY, METERED;NASAL - 0.137MG/SPRAY;0.05MG/SPRAY, SPRAY, METERED;NASAL - 0.05MG/SPRAY, POWDER;INHALATION - 0.05MG/INH, POWDER;INHALATION - 0.1MG/INH, POWDER;INHALATION - 0.25MG/INH, POWDER;INHALATION - 0.03MG/INH, POWDER;INHALATION - 0.055MG/INH, POWDER;INHALATION - 0.113MG/INH, POWDER;INHALATION - 0.232MG/INH, POWDER;INHALATION - 0.055MG/INH;EQ 0.014MG BASE/INH, POWDER;INHALATION - 0.113MG/INH;EQ 0.014MG BASE/INH, POWDER;INHALATION - 0.232MG/INH;EQ 0.014MG BASE/INH, POWDER;INHALATION - 0.1MG/INH;EQ 0.05MG BASE/INH, POWDER;INHALATION - 0.25MG/INH;EQ 0.05MG BASE/INH, POWDER;INHALATION - 0.5MG/INH;EQ 0.05MG BASE/INH, LOTION;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, AEROSOL, METERED;INHALATION - 0.045MG/INH;EQ 0.021MG BASE/INH, AEROSOL, METERED;INHALATION - 0.115MG/INH;EQ 0.021MG BASE/INH, AEROSOL, METERED;INHALATION - 0.23MG/INH;EQ 0.021MG BASE/INH, AEROSOL, METERED;INHALATION - 0.044MG/INH, AEROSOL, METERED;INHALATION - 0.11MG/INH, AEROSOL, METERED;INHALATION - 0.22MG/INH

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 2 SPI Pharma, 1 DKSH, 2 Jai Radhe Sales, 2 Faran Shimi Pharmaceutical, 9 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 10 Actylis, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 11 BASF, 5 DFE Pharma, 2 Finar, 7 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 20 Kerry, 1 Kima Chemical, 10 Microlex e.U, 1 Nanjing Bold Chemical, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 2 Prachin Chemical, 10 Roquette, 8 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 1 The Dow Chemical Company, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

40 Fillers, Diluents & Binders, 23 Direct Compression, 21 Solubilizers, 20 Thickeners and Stabilizers, 18 Topical, 15 Disintegrants & Superdisintegrants, 14 Co-Processed Excipients, 12 Granulation, 12 Parenteral, 10 Emulsifying Agents, 10 Controlled & Modified Release, 7 Film Formers & Plasticizers, 6 Surfactant & Foaming Agents, 6 Rheology Modifiers, 6 Coating Systems & Additives, 3 Taste Masking, 2 Chewable & Orodispersible Aids, 2 Lubricants & Glidants, 1 API Stability Enhancers

DIGITAL CONTENT

11 DATA COMPILATION #PharmaFlow, 142 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 164 Finished Drug Prices, 12 Annual Reports

MARKET PLACE

16 APIs, 4 FDF Dossiers, 1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

573 US Patents, 11 US Exclusivities, 53 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 7 USP, 9 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 20833 / DOSAGE - POWDER;INHALATION - 0.05MG/INH

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
FLUTICASONE PROPIONATE(UNII: O2GMZ0LF5W) (FLUTICASONE - UNII:CUT2W21N7U)	FLUTICASONE PROPIONATE	50ug

Inactive Ingredients

Ingredient Name	A-S Medication Solutions
LACTOSE, UNSPECIFIED FORM(J2B2A4N98G)

Drug Product Composition: Fluticasone Propionate